Topics Covered
We invite you to learn more about:
- The importance of knowing your non-Hodgkin lymphoma (NHL) subtype
- How your NHL subtype guides your treatment goals
- Treatments for slow-growing and aggressive forms of NHL
- The benefit of discussing quality-of-life concerns with your healthcare team
Program Materials
Transcript will be available soon.
/sites/default/files/2021-12/slides_nhl_12.2.21.pdf
/sites/default/files/2022-06/transcript_nhl_12.2.21.pdf
Speaker
Celeste Bello, MD, MSPH
Associate Member
Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL
Program Support
Support for this program is provided by Bristol Myers Squibb; Genentech, Inc. & Biogen and Pharmacyclics, An AbbVie Company & Janssen Biotech.